RGEN - Repligen Non-GAAP EPS of $0.68 beats by $0.10 revenue of $186.76M beats by $2.35M
- Repligen press release ( NASDAQ: RGEN ): Q4 Non-GAAP EPS of $0.68 beats by $0.10 .
- Revenue of $186.76M (+0.1% Y/Y) beats by $2.35M .
-
YEAR 2023 GUIDANCE:
- Total reported revenue is expected to be in the range of $760-$800 million vs. $800.24M consensus. This guidance reflects our expectations for decreased COVID-related revenue (a year-over-year decrease of $100-$110 million), and base organic revenue growth of 12%-16%, or 11%-15% as reported.
- Gross margin is expected to be 52.5%-53.5% on both a GAAP and non-GAAP basis down 400 basis points at the midpoint versus 2022.
- Net income per share (GAAP) is expected to be in the range of $1.96-$2.04 on a fully diluted basis. Adjusted net income per share (non-GAAP) is expected to be in the range of $2.61-$2.69 on a fully diluted basis vs. $2.92 consensus
For further details see:
Repligen Non-GAAP EPS of $0.68 beats by $0.10, revenue of $186.76M beats by $2.35M